Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The Oncologist|April 15, 2011
Sunitinib in metastatic renal cell carcinoma: recommendations for management of noncardiovascular toxicitiesChristian Kollmannsberger, Georg Bjarnason, Patrick Burnett, et al.
The American Journal of Surgical Pathology|October 7, 2017
Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular AnalysisRola M Saleeb, Fadi Brimo, Mina Farag, et al.
Urologic Oncology|July 10, 2019
Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysisMadhur Nayan, Shreya Jalali, Anil Kapoor, et al.
The Journal of Molecular Diagnostics : JMD|May 15, 2012
The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinomaHala Faragalla, Youssef M Youssef, Andreas Scorilas, et al.
Pharmacogenetics and Genomics|June 21, 2021
Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance)Jai N Patel, Chen Jiang, Kouros Owzar, et al.
JCO Global Oncology|November 22, 2023
Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care SystemLuisa M Cardenas, Sunita Ghosh, Antonio Finelli, et al.
The Journal of Urology|July 3, 2020
Impact of Time to Surgery and Surgical Delay on Oncologic Outcomes for Renal Cell CarcinomaBenjamin Shiff, Rodney H Breau, Premal Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy GroupSylvie Giacchetti, Georg Bjarnason, Carlo Garufi, et al.
The Journal of Urology|August 22, 2025
Incidence of local treatment and metastasis during active surveillance for patients with a small renal mass in a national multicenter prospective cohortLuke T Lavallée, Antonio Finelli, Simon Tanguay, et al.
Current Oncology (Toronto, Ont.)|March 27, 2026
Outcomes and Predictors of Recurrence and Survival in Surgically Resected Localized Chromophobe Renal Cell Carcinoma: Results from the Canadian Kidney Cancer Information System (CKCis)Erica Arenovich, Rodney Breau, Ricardo Rendon, et al.
Pageof 3